Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5773351

O=C(CCc1cnoc1-c1ccc(C(F)(F)F)cc1)NCCNc1ccc([N+](=O)[O-])cn1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
ALDH1A1 P00352 2/20 0.42
DPP4 P27487 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 2/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PRKAB2 O43741 1/20 0.35
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAA1 Q13131 1/20 0.35
PRKAG3 Q9UGI9 1/20 0.35
PRKAG2 Q9UGJ0 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5775554 0.82 HDAC4 (0.43) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5773357 0.81 POLB (0.38) POLBALDH1A1DPP4SMN1; SMN2MAPT
Trifluoroacetic Acid SCHEMBL5776657 0.77 MAPT (0.42) SMN1; SMN2MAPT
Trifluoroacetic Acid SCHEMBL5775717 0.77 GSK3B (0.44) SMN1; SMN2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5774050 0.75 TRPV1 (0.43) ALDH1A1MAPTLMNAGAAHTT
Trifluoroacetic Acid SCHEMBL5774844 0.74 HDAC4 (0.40) ALDH1A1MEN1KMT2ALMNAGAA
Trifluoroacetic Acid SCHEMBL5772978 0.74 GSK3B (0.52) ALDH1A1SMN1; SMN2MAPTGAA
Trifluoroacetic Acid SCHEMBL5773866 0.74 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5774568 0.73 LMNA (0.50) POLBALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL5774001 0.72 FFAR1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR POLB 3996/4885ALDH1A1 1045/4885DPP4 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.